With assistance from the Office of Cooperative Research, over 50 companies based on faculty inventions have spun out of Yale and have collectively raised $5 billion in equity capital in the last 15 years. Many of these startups are dedicated to advancing new therapies and medical devices to market by licensing cutting-edge Yale research to one of our many corporate partners.

Yale Pharmaceutical Pipeline

device pipeline

Yale Device and Diagnostic Pipeline

Thursday, September 26, 2013